Hughes, DA;
Nicholls, K;
Sunder-Plassmann, G;
Jovanovic, A;
Feldt-Rasmussen, U;
Schiffmann, R;
Giugliani, R;
... Bichet, DG; + view all
(2019)
Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study.
American Journal of Medical Genetics: Part A
10.1002/ajmg.a.61105.
(In press).
Preview |
Text
Hughes_et_al-2019-American_Journal_of_Medical_Genetics_Part_A.pdf - Published Version Download (698kB) | Preview |
Type: | Article |
---|---|
Title: | Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study |
Location: | United States |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1002/ajmg.a.61105 |
Publisher version: | https://doi.org/10.1002/ajmg.a.61105 |
Language: | English |
Additional information: | © 2019 The Authors. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology |
URI: | https://discovery.ucl.ac.uk/id/eprint/10071991 |
Archive Staff Only
View Item |